Literature DB >> 28012706

Anything goes? Regulation of the neural processes underlying response inhibition in TBI patients.

Laura Moreno-López1, Anne E Manktelow2, Barbara J Sahakian3, David K Menon2, Emmanuel A Stamatakis2.   

Abstract

Despite evidence for beneficial use of methylphenidate in response inhibition, no studies so far have investigated the effects of this drug in the neurobiology of inhibitory control in traumatic brain injury (TBI), even though impulsive behaviours are frequently reported in this patient group. We investigated the neural basis of response inhibition in a group of TBI patients using functional magnetic resonance imaging and a stop-signal paradigm. In a randomised double-blinded crossover study, the patients received either a single 30mg dose of methylphenidate or placebo and performed the stop-signal task. Activation in the right inferior frontal gyrus (RIFG), an area associated with response inhibition, was significantly lower in patients compared to healthy controls. Poor response inhibition in this group was associated with greater connectivity between the RIFG and a set of regions considered to be part of the default mode network (DMN), a finding that suggests the interplay between DMN and frontal executive networks maybe compromised. A single dose of methylphenidate rendered activity and connectivity profiles of the patients RIFG near normal. The results of this study indicate that the neural circuitry involved in response inhibition in TBI patients may be partially restored with methylphenidate. Given the known mechanisms of action of methylphenidate, the effect we observed may be due to increased dopamine and noradrenaline levels.
Copyright © 2016 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Functional connectivity; Methylphenidate; Response inhibition; Traumatic brain injury

Mesh:

Substances:

Year:  2016        PMID: 28012706     DOI: 10.1016/j.euroneuro.2016.12.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  7 in total

1.  Frontal brain injury chronically impairs timing behavior in rats.

Authors:  Taylor L Scott; Cole Vonder Haar
Journal:  Behav Brain Res       Date:  2018-09-10       Impact factor: 3.332

2.  Unilateral parietal brain injury increases risk-taking on a rat gambling task.

Authors:  Jenny E Ozga-Hess; Cory Whirtley; Christopher O'Hearn; Kristen Pechacek; Cole Vonder Haar
Journal:  Exp Neurol       Date:  2020-01-31       Impact factor: 5.330

3.  Cocaine self-administration is increased after frontal traumatic brain injury and associated with neuroinflammation.

Authors:  Cole Vonder Haar; Jacqueline-Marie N Ferland; Sukhbir Kaur; Lara-Kirstie Riparip; Susanna Rosi; Catharine A Winstanley
Journal:  Eur J Neurosci       Date:  2018-10-10       Impact factor: 3.386

4.  Working Memory after Traumatic Brain Injury: The Neural Basis of Improved Performance with Methylphenidate.

Authors:  Anne E Manktelow; David K Menon; Barbara J Sahakian; Emmanuel A Stamatakis
Journal:  Front Behav Neurosci       Date:  2017-04-05       Impact factor: 3.558

Review 5.  Methylphenidate Treatment of Cognitive Dysfunction in Adults After Mild to Moderate Traumatic Brain Injury: Rationale, Efficacy, and Neural Mechanisms.

Authors:  Harvey Levin; Maya Troyanskaya; JoAnn Petrie; Elisabeth A Wilde; Jill V Hunter; Tracy J Abildskov; Randall S Scheibel
Journal:  Front Neurol       Date:  2019-09-12       Impact factor: 4.003

6.  Cathodal Transcranial Direct-Current Stimulation Selectively Decreases Impulsivity after Traumatic Brain Injury in Rats.

Authors:  Kris M Martens; Kristen M Pechacek; Cassandra G Modrak; Virginia J Milleson; Binxing Zhu; Cole Vonder Haar
Journal:  J Neurotrauma       Date:  2019-06-17       Impact factor: 5.269

7.  Effects of Methylphenidate on Cognitive Function in Adults with Traumatic Brain Injury: A Meta-Analysis.

Authors:  Yung-Jiun Chien; Yung-Chen Chien; Chien-Ting Liu; Hsin-Chi Wu; Chun-Yu Chang; Meng-Yu Wu
Journal:  Brain Sci       Date:  2019-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.